Founders Capital Management - AGILE THERAPEUTICS INC ownership

AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 41 filers reported holding AGILE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Founders Capital Management ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$10,0000.0%20,0000.0%0.01%0.0%
Q4 2021$10,000
+100.0%
20,000
+300.0%
0.01%
+100.0%
Q3 2021$5,000
-61.5%
5,000
-50.0%
0.00%
-62.5%
Q2 2021$13,000
+30.0%
10,000
+100.0%
0.01%
+14.3%
Q1 2021$10,0005,0000.01%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 15,919,925$15,301,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 735,000$706,0000.09%
INVESTOR AB 3,510,189$3,370,0000.09%
GSA CAPITAL PARTNERS LLP 586,491$564,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 335,735$322,0000.05%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 70,000$67,0000.02%
Summit Global Investments 126,000$121,0000.01%
Ergoteles LLC 211,611$203,0000.01%
Centric Wealth Management 10,000$10,0000.00%
GRIMES & COMPANY, INC. 99,744$96,0000.00%
View complete list of AGILE THERAPEUTICS INC shareholders